Are we ready to embrace novel therapeutic targets for women with AR-positive or AR-negative metastatic Triple-Negative Breast Cancer ?
Crossref DOI link: https://doi.org/10.32948/ajo.2021.07.28
Published Online: 2021-08-06
Published Print: 2021-08-06
Update policy: https://doi.org/10.32948/asme.crossmark.policy
(Kate) Rygie, Katarzyna
Publication History
Received: 2021-3-10
Accepted: 2021-7-28
